Towards Healthcare
Cancer Vaccines Market Size and Top Companies | 11.44% - CAGR Growth

Cancer Vaccines Market Size Envisioned at USD 30.16 Billion by 2033

The report covers Cancer Vaccines Market Companies and Segments Outlook by type, it includes preventive cancer vaccines, therapeutic cancer vaccines and others. By indication, it analyzes vaccines targeting cervical, prostate and other indications. Technologically, it examines recombinant cancer vaccines, viral vector and DNA cancer vaccines, whole-cell cancer vaccines, and others. Distribution channels focusing on hospitals and government suppliers. The report offers the value (in USD Billion) for the above segments.

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Cancer Vaccines Market Assessment

  • Overview
  • Global Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Preventive Cancer Vaccines
    • Therapeutic Cancer Vaccines
    • Others
    • Others
  • Global Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Cervical Cancer
    • Prostate Cancer
    • Other Indications
  • Global Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Recombinant Cancer Vaccines
    • Viral Vector and DNA Cancer Vaccines
    • Whole-cell Cancer Vaccines
      Others
  • Global Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospitals
    • Government Suppliers
  • Global Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
    • North America
    • Europe
    • Asia-Pacific
    • Latin America
    • Middle East & Africa (MEA)

North America Cancer Vaccines Market Assessment

  • Overview
  • Regional trends
  • North America Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Preventive Cancer Vaccines
    • Therapeutic Cancer Vaccines
    • Others
  • North America Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Cervical Cancer
    • Prostate Cancer
    • Other Indications
  • North America Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Recombinant Cancer Vaccines
    • Viral Vector and DNA Cancer Vaccines
    • Whole-cell Cancer Vaccines
    • Others
  • North America Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospitals
    • Government Suppliers

Europe Cancer Vaccines Market Assessment

  • Overview
  • Regional trends
  • Europe Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Preventive Cancer Vaccines
    • Therapeutic Cancer Vaccines
    • Others
  • Europe Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Cervical Cancer
    • Prostate Cancer
    • Other Indications
  • Europe Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Recombinant Cancer Vaccines
    • Viral Vector and DNA Cancer Vaccines
    • Whole-cell Cancer Vaccines
    • Others
  • Europe Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospitals
    • Government Suppliers

Asia-Pacific Cancer Vaccines Market Assessment

  • Overview
  • Regional trends
  • Asia-Pacific Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Preventive Cancer Vaccines
    • Therapeutic Cancer Vaccines
    • Others
  • Asia-Pacific Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Cervical Cancer
    • Prostate Cancer
    • Other Indications
  • Asia-Pacific Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Recombinant Cancer Vaccines
    • Viral Vector and DNA Cancer Vaccines
    • Whole-cell Cancer Vaccines
    • Others
  • Asia-Pacific Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospitals
    • Government Suppliers

Latin America Cancer Vaccines Market Assessment

  • Overview
  • Regional trends
  • Latin America Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Preventive Cancer Vaccines
    • Therapeutic Cancer Vaccines
    • Others
  • Latin America Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Cervical Cancer
    • Prostate Cancer
    • Other Indications
  • Latin America Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Recombinant Cancer Vaccines
    • Viral Vector and DNA Cancer Vaccines
    • Whole-cell Cancer Vaccines
    • Others
  • Latin America Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospitals
    • Government Suppliers

Middle East and Africa Cancer Vaccines Market Assessment

  • Overview
  • Regional trends
  • Middle East and Africa Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Preventive Cancer Vaccines
    • Therapeutic Cancer Vaccines
    • Others
  • Middle East and Africa Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Cervical Cancer
    • Prostate Cancer
    • Other Indications
  • Middle East and Africa Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Recombinant Cancer Vaccines
    • Viral Vector and DNA Cancer Vaccines
    • Whole-cell Cancer Vaccines
    • Others
  • Middle East and Africa Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospitals
    • Government Suppliers

Company Profiles

  • Generex Biotechnology Corporation
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Immunocellular Therapeutics, Ltd
  • Vaccinogen, Inc.
  • GlaxoSmithKline plc (GSK)
  • Advaxis Inc.
  • Dynavax Technologies Corporation
  • Merck & Co., Inc.
  • SANPOWER GROUP CO. LTD. (DENDEREON CORPORATION)
  • UbiVac
  • Amgen Inc.

Conclusion & Recommendations

Proceed To Buy

USD 5400
USD 3800
USD 2100
USD 2100
USD 7500

About The Author

Deepa has certified the degree of Master’s in Pharmacy in the Pharmaceutical Quality Assurance department from Dr D.Y. Patil College of Pharmacy. Her research is focused on the healthcare industry. She is the author or co-author of four Review Articles, which include Solid dispersion a strategic method for poorly soluble drugs and solubility improvement techniques for poorly soluble drugs, Herbal Drugs Used In Treatment Of Cataracts, Nano sponges And Their Application in Cancer Prevention and Ayurvedic Remedies of Peptic ulcer. She has also published a Research Article on the Formulation and Evaluation of Mucoadhesive Tablets of Miconazole cocrystal which was published in GIS Science Journal Volume 9 Issue 8. Her passion for secondary research and desire to take on the challenge of solving unresolved issues is making her flourish is the in the research sector.

FAQ's

Yes. Vaccines used for treatment are called immunotherapy, treatment vaccines, or therapeutic vaccines. These vaccines prevent the reoccurrence of cancer and the destruction of cancer cells post-treatment, as well as prevent cancer from spreading.

Lung cancer, lymphoma, prostate cancer, ovarian cancer, melanoma, breast cancer, mesothelioma, cervical cancer and reproductive organ cancer.

Research, development, and clinical trials are ongoing to develop combination cancer therapies, oncolytic virus-based vaccines, personalized vaccines, and in situ vaccines or intratumoral therapies.

World Health Organization, National Cancer Institute, National Library of Medicine, Press Information Bureau and Cancer Research Institute.

Warning: include(report-detail-graphs.php): failed to open stream: No such file or directory in /home/thealthcre/public_html/report-toc.php on line 517

Warning: include(): Failed opening 'report-detail-graphs.php' for inclusion (include_path='.:/opt/cpanel/ea-php74/root/usr/share/pear') in /home/thealthcre/public_html/report-toc.php on line 517